Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
14C-E7080 metabolism and elimination study in advanced solid tumors or lymphomas
NL-OMON33844Not yet recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lenvatinib in Nonhematologic neoplasms and lymphoma, sponsored by Eisai Co., Ltd. Primary endpoint: Pharmacokinetic and metabolic profile. Planned start Mar 2009; status: not yet recruiting.
02
Drugs
lenvatinib
03
Conditions
Nonhematologic neoplasmslymphoma
Beyond the preview
Go deeper on NL-OMON33844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33844.